Spanish medtech caught in Euro200 million contributions law
This article was originally published in Clinica
Suppliers of medical products to Spain's national healthcare system (SNS) will soon be obliged to contribute a percentage of their sales to support R&D and regional services delivery, under new legislation. The move is expected to generate Euros200m ($258m) per annum, double the current level.
You may also be interested in...
Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.